50,000 People taking part in Chinese Corona Vaccine phase 3 trials

Vastavam web: Around 50,000 people in a number of countries are participating in phase 3 clinical trials of a coronavirus vaccine developed by the China National Biotec Group (CNBG), the company said on Saturday in a press release. “The third phase of clinical trials of the inactivated CNBG vaccine against COVID-19 is significantly accelerating, and clinical trials are already underway in several countries, including Bahrain, UAE, Morocco, Peru, Argentina, with about 50,000 people participating,” the CNGB said.